Axsome Therapeutics (AXSM) Receivables (2022 - 2026)
Axsome Therapeutics (AXSM) posted Receivables of $305.99 million for Q2 2026, up 40.0% from $218.64 million a year earlier and up 12.0% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Receivables (2022 - 2026) Analysis & Trends
At the end of FY2025, Axsome Therapeutics' Receivables came in at $246.67 million, up 58.6% from FY2024.
- Annual Receivables has increased for three consecutive years, with a three-year compound annual growth rate of 74.0% (FY2022 to FY2025).
- In prior years, Axsome Therapeutics' Receivables was $155.51 million in FY2024 (+44.9%), $107.32 million in FY2023 (+129.3%) and $46.8 million in FY2022.
- The Q2 2026 figure stands as the highest quarterly Receivables in data going back to Q2 2022.
- On a year-over-year basis, Receivables has increased in each of the last 13 quarters, with growth averaging 53.5% over the last eight quarters.
- The year-over-year growth in Receivables has ranged between 40.0% (Q2 2026) and 413.8% (Q2 2023) over the last five years.
- According to Business Quant data, Receivables for the three prior quarters was $273.19 million (Q1 2026), $246.67 million (Q4 2025) and $215.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Axsome Therapeutics | 8.09 Bn | 6.82 Bn | 204.81 Mn | 305.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 305.99 Mn |
| Mar 31, 2026 | 273.19 Mn |
| Dec 31, 2025 | 246.67 Mn |
| Sep 30, 2025 | 215.85 Mn |
| Jun 30, 2025 | 218.64 Mn |
| Mar 31, 2025 | 176.18 Mn |
| Dec 31, 2024 | 155.51 Mn |
| Sep 30, 2024 | 138.40 Mn |
| Jun 30, 2024 | 133.53 Mn |
| Mar 31, 2024 | 115.12 Mn |
| Dec 31, 2023 | 107.32 Mn |
| Sep 30, 2023 | 88.39 Mn |
| Jun 30, 2023 | 83.06 Mn |
| Mar 31, 2023 | 57.81 Mn |
| Dec 31, 2022 | 46.80 Mn |
| Sep 30, 2022 | 20.30 Mn |
| Jun 30, 2022 | 16.17 Mn |
API Access
Axsome Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();